iifl-logo

Natco Pharma Ltd Historical Data

877.25
(-0.62%)
Nov 28, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Natco Pharma Ltd Historical Data

29/10/2025calendar-icon
29/11/2025calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

29-Oct-2025

827.35

832823.95828.117,33721,63,73,478.851,65,808

30-Oct-2025

828.8

835.6824.25833.313,33518,53,22,846.11,13,627

31-Oct-2025

833.55

838.9819819.925,41934,03,61,789.62,40,980

03-Nov-2025

819.9

833.5809.9831.535,81239,63,44,800.252,40,555

04-Nov-2025

825.1

837.2818.8819.8525,28229,03,54,123.052,33,808

06-Nov-2025

826.7

826.7795.2800.542,93553,65,33,697.053,57,971

07-Nov-2025

802.95

805795.1802.532,87230,72,42,976.352,09,277

10-Nov-2025

808.1

808.1793.1798.830,50029,92,89,721.152,21,967

11-Nov-2025

800.9

803.25792.05792.9528,11325,04,36,2882,03,107

12-Nov-2025

797.4

829797.2822.3541,99873,22,41,092.854,01,770

13-Nov-2025

828

831.95821.15826.1519,34837,85,24,531.11,88,667

14-Nov-2025

827.9

830807812.6540,18979,74,21,934.053,18,781

17-Nov-2025

812.65

825.9805.6820.926,52742,57,95,212.12,62,193

18-Nov-2025

821.95

824.9812.1814.5518,40623,23,75,441.951,65,860

19-Nov-2025

818

848811.4830.1590,0821,93,55,63,688.655,34,931

20-Nov-2025

831.7

887.65828.3869.31,71,6736,75,79,94,376.2514,55,008

21-Nov-2025

869

872.9857864.835,61363,27,04,696.32,70,903

24-Nov-2025

855.5

864.1837.35841.2540,30883,00,01,968.454,59,497

25-Nov-2025

841.25

850.95826.9583425,36239,01,55,412.051,79,936

26-Nov-2025

834

938.15834927.44,07,29217,72,17,16,274.2517,88,567

27-Nov-2025

927

934.5876882.751,46,3264,87,76,22,056.559,45,244

28-Nov-2025

887.1

900.9869.25877.2561,3721,89,39,30,563.753,58,280

Natco Pharma: Related NEWS

Top Stocks for Today - 24th November 2025

Here are some of the stocks that may see significant price movement today: Tata Power, Tata Chemicals, Tata Consultancy, etc.

24 Nov 2025|07:54 AM
Read More
NATCO Pharma receives 7 observations from USFDA

In a statement, NATCO Pharma stated it is confident of addressing all the observations within the stated time frame.

20 Jun 2025|12:25 PM
Read More
Top Stocks for Today - 20th June 2025

Here are some of the stocks that may see significant price movement today: United Spirits, Biocon, NATCO Pharma, etc.

20 Jun 2025|06:07 AM
Read More
Natco Pharma Q4 Net Profit Rises 5% YoY to ₹406 Crore

Quarterly revenue came in at ₹1,287.3 crore, a 16% YoY increase from ₹1,110.3 crore in Q4 FY24, led by robust performance in key segments.

30 May 2025|12:15 AM
Read More
Natco Pharma Gets USFDA Approval for Bosentan 32mg Tablets

The drug enhances the flow of blood through the lungs, allowing children with PAH to breathe and improve their ability to engage in physical activity.

12 Feb 2025|11:14 AM
Read More
Natco Pharma Sells Telangana Land for ₹115.57 Crore

The company was ensured that the sale of the land and building did not constitute part of its operational assets so that the sale will, in no way, impact the company's business operations

1 Dec 2024|07:16 PM
Read More
Natco Pharma Q2 Profit Surges 83%, Declares Interim Dividend

The revenue for the September quarter rose by 33% to ₹1,371 crore from ₹1,031 crore in the corresponding period last year.

12 Nov 2024|10:26 PM
Read More
Natco Pharma settles US patent case over generic Ozempic

According to data from the BSE index, the stock has achieved multibagger gains over the last two years, climbing 122.04%.

7 Oct 2024|01:52 PM
Read More
Cancer Patients Benefit as GST on Medications Slashed

The plan to reduce the GST on these drugs aims to significantly reduce the overall cost of cancer treatment.

10 Sep 2024|12:22 PM
Read More
Natco Pharma invests $8 million in US biotech firm eGenesis

Natco Pharma disclosed that its subsidiary will invest USD 8 million in eGenesis, acquiring a total of 40,629,761 shares.

4 Sep 2024|03:28 PM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.